Invitrogen Corporation provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. Invitrogen has multiple locations in North America including Madison, Wisconsin. The company employs approximately 4,700 scientists and other professionals and had revenues of approximately $1.3 billion in 2007.

Takara Bio U.S.A. located in Madison, Wisconsin, distributes research biological products manufactured by Takara Bio Inc. (Japan) in North and South America. Takara Bio USA is a division of Clontech Laboratories, Inc. which is headquartered in Mountain View, CA. Clontech Laboratories Inc., is a wholly owned subsidiary of Takara Bio Inc. (Japan). Takara Bio Inc. holds worldwide patents on Long and Accurate (LA) PCR, and has built a reputation for producing high-performance PCR reagents and kits. All of Takara’s Bio's Taq products are licensed for PCR. Takara Bio's line of high-quality molecular biology reagents and kits includes restriction and modifying enzymes, kits for cloning and ligation of DNA, sequencing and mutagenesis, and high-efficiency gene transfer.

Roche NimbleGen is a leading innovator, manufacturer and supplier of a proprietary suite of DNA microarrays, consumables, instruments and services. Roche NimbleGen uniquely produces high-density arrays of long oligo probes that provide greater information content and higher data quality necessary for studying the full diversity of genomic and epigenomic variation. The improved performance is made possible by Roche NimbleGen’s proprietary Maskless Array Synthesis (MAS) technology, which uses digital light processing and rapid, high-yield photochemistry to synthesize long oligo, high-density DNA microarrays with extreme flexibility. For more information about Roche NimbleGen, please visit the company’s website at www.nimblegen.com.

Third Wave is a growing leader in molecular diagnostics, providing DNA and RNA analysis products to clinical, research, and agricultural customers. Third Wave is one of the only companies in the emerging molecular diagnostics market with a unique chemistry—the functional backbone of any molecular test—that they are commercializing to capture opportunities in this valuable market. They have more than 180 clinical testing customers and the list continues to grow. In the United States, they serve most major clinical laboratories that perform tests in the molecular diagnostics testing market. Third Wave has also established a strong presence in Japan.

Epic Systems Corporation develops integrated ambulatory, inpatient, and payor software that covers clinical, access, and revenue cycle areas. Epic provides the information backbone for many of the country’s healthcare organizations, pediatric facilities, and academic institutions, which use Epic’s system to link thousands of concurrent users with a single source of patient-centric data. The company is employee-owned and based in Wisconsin, where it builds all of its software applications.

EMD develops, manufactures and distributes innovative life science research reagents under the Novagen®, Calbiochem® and Novabiochem® brands. These product brands provide a single source for a broad range of products and services used in disease research and drug discovery. The Madison EMD facility develops, produces and markets the brand Novagen® which offers world-class protein expression and purification products. Our customers include pharmaceutical and biotechnology companies, academic and research institutions, hospitals and government laboratories working at the cutting edge of research. Novagen, Calbiochem and Novabiochem are brands of EMD Chemicals which is an affiliate of Merck KGaA, Darmstadt, Germany.

Focused on cGMP manufacturing, process development and contract services for all pharmaceutical customers, SAFC Pharma provides fit-for-purpose support at the preclinical stage through clinical development and commercialization by offering a wide range of medicinal chemistry services that facilitate faster and more economical delivery of higher quality drug candidates. Expertise in medicinal chemistry, cGMP high-potency pilot-scale manufacturing (new Pilot Plant at the Madison, Wisconsin facility) and commercial-capacity cGMP production for new chemical entities. SAFC is one of the few CRO organizations to have Solid State Chemistry (SSC) capability coupled with process research, development and cGMP manufacturing services. A top 10 fine chemical company.